| 3MY0 | X:195-200; X:195-200; X:195-200; X:195-200; X:195-200; X:195-200; X:195-200; X:195-200; X:195-200; X:195-200; X:195-200; X:195-200; X:195-200; X:195-200; X:195-200; X:195-200; X:195-200; X:195-200; X:195-200; X:195-200; X:195-200; X:195-200; X:195-200 | CRYSTAL STRUCTURE OF THE ACVRL1 (ALK1) KINASE DOMAIN BOUND TO LDN-193189 |
| 3MTF | B:202-206; B:202-206 | CRYSTAL STRUCTURE OF THE ACVR1 KINASE IN COMPLEX WITH A 2-AMINOPYRIDINE INHIBITOR |
| 3OOM | A:203-206 | CRYSTAL STRUCTURE OF THE ACVR1 KINASE DOMAIN IN COMPLEX WITH THE IMIDAZO[1,2-B]PYRIDAZINE INHIBITOR K00507 |
| 3Q4U | D:201-206; D:201-206; D:201-206; D:201-206 | CRYSTAL STRUCTURE OF THE ACVR1 KINASE DOMAIN IN COMPLEX WITH LDN-193189 |
| 3MDY | C:174-202; C:174-202 | CRYSTAL STRUCTURE OF THE CYTOPLASMIC DOMAIN OF THE BONE MORPHOGENETIC PROTEIN RECEPTOR TYPE-1B (BMPR1B) IN COMPLEX WITH FKBP12 AND LDN-193189 |
| 1PY5 | A:200-203 | CRYSTAL STRUCTURE OF TGF-BETA RECEPTOR I KINASE WITH INHIBITOR |
| 1RW8 | A:200-203 | CRYSTAL STRUCTURE OF TGF-BETA RECEPTOR I KINASE WITH ATP SITE INHIBITOR |
| 1VJY | A:201-203 | CRYSTAL STRUCTURE OF A NAPHTHYRIDINE INHIBITOR OF HUMAN TGF-BETA TYPE I RECEPTOR |
| 2WOT | A:200-203 | ALK5 IN COMPLEX WITH 4-((5,6-DIMETHYL-2-(2-PYRIDYL)-3-PYRIDYL)OXY)-N-(3,4,5-TRIMETHOXYPHENYL)PYRIDIN-2-AMINE |
| 2WOU | A:200-203 | ALK5 IN COMPLEX WITH 4-((4-((2,6-DIMETHYL-3-PYRIDYL)OXY)-2-PYRIDYL)AMINO)BENZENESULFONAMIDE |
| 2X7O | E:175-203; E:175-203; E:175-203; E:175-203; E:175-203 | CRYSTAL STRUCTURE OF TGFBRI COMPLEXED WITH AN INDOLINONE INHIBITOR |
| 3KCF | E:175-203; E:175-203; E:175-203; E:175-203; E:175-203 | CRYSTAL STRUCTURE OF TGFBRI COMPLEXED WITH A PYRAZOLONE INHIBITOR |
)
)